Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Aggression × Rituximab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 366 Lymphoma 358 Lymphoma, Non-Hodgkin 299 Leukemia, Lymphocytic, Chronic, B-Cell 272 Lymphoma, Follicular 266 Lymphoma, Mantle-Cell 200 Lymphoma, B-Cell, Marginal Zone 143 Leukemia 114 Burkitt Lymphoma 102 Lymphoma, B-Cell 97 Waldenstrom Macroglobulinemia 93 Precursor Cell Lymphoblastic Leukemia-Lymphoma 84 Recurrence 75 Hodgkin Disease 56 Lymphoma, Large-Cell, Immunoblastic 53 Neoplasms 35 Myelodysplastic Syndromes 25 Multiple Myeloma 24 Leukemia, Myeloid, Acute 24 Lymphoma, Large-Cell, Anaplastic 22 Dendritic Cell Sarcoma, Interdigitating 21 Leukemia, Hairy Cell 18 Hematologic Neoplasms 18 Leukemia, Prolymphocytic 15 Intraocular Lymphoma 15 Neoplasms, Plasma Cell 12 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 11 Lymphoma, T-Cell 11 Leukemia, Myelomonocytic, Chronic 10 Leukemia, Myeloid, Accelerated Phase 10

Interventions

selinexor 1 pegfilgrastim 1 midostaurin 1 glofitamab 1 Topotecan 1 Rituximab 1 Prednisone 1 Paclitaxel 1 Methylprednisolone 1 Immunologic Techniques 1 Ifosfamide 1 Flow Cytometry 1 Etoposide 1 Dexamethasone 1 Clofarabine 1 Carboplatin 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡